NASDAQ:CLBT Cellebrite DI (CLBT) Stock Price, News & Analysis $11.37 +0.17 (+1.52%) Closing price 10/6/2026 04:00 PM EasternExtended Trading$11.30 -0.07 (-0.60%) As of 10/6/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Cellebrite DI Stock (NASDAQ:CLBT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Cellebrite DI alerts:Sign Up Key Stats Today's Range$11.21▼$11.4450-Day Range$10.44▼$16.0352-Week Range$9.58▼$19.98Volume1.39 million shsAverage Volume2.89 million shsMarket Capitalization$2.84 billionP/E Ratio51.68Dividend YieldN/APrice Target$16.70Consensus RatingModerate Buy Company Overview Cellebrite DI Ltd. is a digital intelligence company that develops technology for collecting, managing and analyzing digital evidence. Its solutions are designed to help law enforcement agencies, public safety organizations, government bodies and enterprises investigate activity involving mobile devices, computers, cloud services and other digital sources. The company’s product portfolio includes tools for mobile-device extraction and digital forensics, investigative analytics, evidence management and collaboration. Its offerings include the UFED platform, Inseyets digital forensics solutions, Pathfinder investigative analytics and Guardian, a cloud-based platform intended to support the secure management and sharing of digital evidence and investigative workflows. Founded in Israel, Cellebrite serves customers in numerous countries through a global sales and support network. The company became publicly traded on the Nasdaq under the symbol CLBT in 2021 following its business combination with special purpose acquisition company TWC Tech Holdings II Corp. Cellebrite’s customers primarily include government and law enforcement organizations, although it also provides solutions for corporate and other investigative users.AI Generated. May Contain Errors. Read More Cellebrite DI Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks86th Percentile Overall ScoreCLBT MarketRank™: Cellebrite DI scored higher than 86% of companies evaluated by MarketBeat, and ranked 94th out of 597 stocks in the technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.3 / 5Analyst RatingModerate Buy Consensus RatingCellebrite DI has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no strong buy ratings, 5 buy ratings, no hold ratings, and 1 sell rating.Upside PotentialCellebrite DI has a consensus price target of $16.70, representing about 46.9% upside from its current price of $11.37.Amount of Analyst CoverageCellebrite DI has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Cellebrite DI's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth37.84% Earnings GrowthEarnings for Cellebrite DI are expected to grow by 37.84% in the coming year, from $0.37 to $0.51 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cellebrite DI is 51.68, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 44.75.Price to Earnings Ratio vs. SectorThe P/E ratio of Cellebrite DI is 51.68, which means that it is trading at a less expensive P/E ratio than the Technology sector average P/E ratio of about 82.33.Price to Earnings Growth RatioCellebrite DI has a PEG Ratio of 1.72. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioCellebrite DI has a P/B Ratio of 5.63. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Cellebrite DI's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.02% of the float of Cellebrite DI has been sold short.Short Interest Ratio / Days to CoverCellebrite DI has a short interest ratio ("days to cover") of 3.49, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cellebrite DI has recently increased by 14.14%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCellebrite DI does not currently pay a dividend.Dividend GrowthCellebrite DI does not have a long track record of dividend growth. News and Social Media2.0 / 5News Sentiment0.25 News SentimentCellebrite DI has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.44 average news sentiment score of Technology companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Cellebrite DI this week, compared to 4 articles on an average week.Search InterestOnly 1 people have searched for CLBT on MarketBeat in the last 30 days. This is a decrease of -86% compared to the previous 30 days.MarketBeat Follows5 people have added Cellebrite DI to their MarketBeat watchlist in the last 30 days. This is an increase of 25% compared to the previous 30 days. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Cellebrite DI insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,344,724.00 in company stock.Percentage Held by Insiders5.70% of the stock of Cellebrite DI is held by insiders.Percentage Held by Institutions45.88% of the stock of Cellebrite DI is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Cellebrite DI's insider trading history. Receive CLBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cellebrite DI and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CLBT Stock News HeadlinesINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. – CLBTOctober 6 at 5:14 PM | globenewswire.comCellebrite DI (NASDAQ:CLBT) and Agora (NASDAQ:API) Head to Head AnalysisOctober 2, 2026 | americanbankingnews.comSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely. | Altimetry (Ad)INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. - CLBTOctober 1, 2026 | prnewswire.comCellebrite DI (NASDAQ:CLBT) and Cadence Design Systems (NASDAQ:CDNS) Head to Head ComparisonOctober 1, 2026 | americanbankingnews.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. – CLBTSeptember 29, 2026 | globenewswire.comCellebrite's 2026 Outlook: Subscription Pivot Weighs on the Stock Today, Helps Lead a Future ReboundSeptember 29, 2026 | fool.comContrasting Cellebrite DI (NASDAQ:CLBT) & Aurora Mobile (NASDAQ:JG)September 26, 2026 | americanbankingnews.comSee More Headlines CLBT Stock Analysis - Frequently Asked Questions How have CLBT shares performed this year? Cellebrite DI's stock was trading at $18.03 at the beginning of the year. Since then, CLBT stock has decreased by 36.9% and is now trading at $11.37. How were Cellebrite DI's earnings last quarter? Cellebrite DI Ltd. (NASDAQ:CLBT) posted its earnings results on Wednesday, February, 11th. The company reported $0.14 EPS for the quarter, meeting analysts' consensus estimates of $0.14. The business's revenue for the quarter was up 28.8% on a year-over-year basis. Read the conference call transcript. How do I buy shares of Cellebrite DI? Shares of CLBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cellebrite DI own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cellebrite DI investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), TotalEnergies (TTE) and Southern First Bancshares (SFST). Company Calendar Last Earnings2/11/2026Today10/06/2026Next Earnings (Estimated)11/11/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 CLBT's financial health is in the Red zone, according to TradeSmith. CLBT has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorTechnology Industry Software Sub-IndustryApplication Software Current SymbolNASDAQ:CLBT CIK1854587 Webwww.cellebrite.com Phone972-73-394-8000Fax972-3924-7104Employees1,285Year Founded1999Price Target and Rating Average Price Target for Cellebrite DI$16.70 High Price Target$25.00 Low Price Target$12.50 Potential Upside/Downside+46.9%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage6 Analysts Profitability EPS (Trailing Twelve Months)$0.22 Trailing P/E Ratio51.68 Forward P/E Ratio30.73 P/E Growth1.72Net Income$78.33 million Net Margins11.43% Pretax Margin14.66% Return on Equity15.58% Return on Assets8.29% Debt Debt-to-Equity RatioN/A Current Ratio1.62 Quick Ratio1.60 Sales & Book Value Annual Sales$514.29 million Price / Sales5.51 Cash Flow$0.41 per share Price / Cash Flow27.72 Book Value$2.02 per share Price / Book5.63Miscellaneous Outstanding Shares249,440,000Free Float235,222,000Market Cap$2.84 billion OptionableOptionable Beta1.14 Social Links 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (NASDAQ:CLBT) was last updated on 10/7/2026 by MarketBeat.com Staff. From Our PartnersThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellebrite DI Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cellebrite DI With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
